KFS
Kurt F. Somerville Portfolio holdings
AUM
$594M
This Quarter Return
+0.59%
1 Year Return
+12.39%
3 Year Return
+68.79%
5 Year Return
+108.17%
10 Year Return
+271.21%
AUM
$248M
AUM Growth
+$248M
(-3.4%)
Cap. Flow
-$6.6M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
37.68%
Holding
107
New
4
Increased
19
Reduced
48
Closed
5
Top Buys
| 1 |
XLNX
Xilinx Inc
XLNX
|
$417K |
| 2 |
Xylem
XYL
|
$378K |
| 3 |
Amgen
AMGN
|
$229K |
| 4 |
Fiserv
FI
|
$226K |
| 5 |
Perrigo
PRGO
|
$204K |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$2.8M |
| 2 |
Canadian National Railway
CNI
|
$648K |
| 3 |
Exxon Mobil
XOM
|
$476K |
| 4 |
TotalEnergies
TTE
|
$404K |
| 5 |
GSK
GSK
|
$390K |
Sector Composition
| 1 | Technology | 23.39% |
| 2 | Healthcare | 22.07% |
| 3 | Industrials | 18.94% |
| 4 | Energy | 12.7% |
| 5 | Consumer Staples | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cisco
CSCO
$268B
| $3.39M | 1.37% |
134,768
-1,601
| -1% | -$40.3K |
|
27
Johnson Controls International
JCI
$68.9B
| $3.27M | 1.32% |
74,345
+1,120
| +2% | +$49.2K |
|
28
GE Aerospace
GE
$293B
| $3.15M | 1.27% |
122,746
| – | – |
|
29
Abbott
ABT
$230B
| $3.08M | 1.24% |
73,965
+1,720
| +2% | +$71.6K |
|
30
NXP Semiconductors
NXPI
$57.5B
| $2.97M | 1.2% |
43,440
-2,100
| -5% | -$144K |
|
31
Pembina Pipeline
PBA
$21.9B
| $2.84M | 1.15% |
67,410
-1,025
| -1% | -$43.2K |
|
32
IBM
IBM
$227B
| $2.7M | 1.09% |
14,220
-783
| -5% | -$149K |
|
|
33
Perrigo
PRGO
$3.21B
| $2.48M | 1% |
16,537
+1,357
| +9% | +$204K |
|
|
ABB
34
DELISTED
ABB Ltd.
ABB
| $2.48M | 1% |
110,761
-15,124
| -12% | -$339K |
|
35
Merck
MRK
$210B
| $1.83M | 0.74% |
30,922
-335
| -1% | -$19.9K |
|
36
Target
TGT
$42B
| $1.81M | 0.73% |
28,859
+3,024
| +12% | +$190K |
|
37
IPG Photonics
IPGP
$3.42B
| $1.53M | 0.62% |
22,265
+2,675
| +14% | +$184K |
|
38
Union Pacific
UNP
$132B
| $1.52M | 0.61% |
13,996
-300
| -2% | -$32.5K |
|
|
XLNX
39
DELISTED
Xilinx Inc
XLNX
| $1.51M | 0.61% |
35,565
+9,850
| +38% | +$417K |
|
|
40
GSK
GSK
$79.3B
| $1.5M | 0.61% |
32,675
-8,485
| -21% | -$390K |
|
41
AbbVie
ABBV
$374B
| $1.48M | 0.6% |
25,640
-700
| -3% | -$40.5K |
|
42
ConocoPhillips
COP
$118B
| $1.48M | 0.6% |
19,366
| – | – |
|
43
Deere & Co
DE
$127B
| $1.34M | 0.54% |
16,375
-1,425
| -8% | -$117K |
|
44
Colgate-Palmolive
CL
$67.7B
| $1.28M | 0.52% |
19,612
+400
| +2% | +$26.1K |
|
45
General Mills
GIS
$26.6B
| $1.28M | 0.52% |
25,338
-100
| -0.4% | -$5.04K |
|
46
Pfizer
PFE
$141B
| $1.21M | 0.49% |
40,910
| – | – |
|
|
DD
47
DELISTED
Du Pont De Nemours E I
DD
| $1.16M | 0.47% |
16,185
-600
| -4% | -$43.1K |
|
48
Norfolk Southern
NSC
$62.4B
| $1.14M | 0.46% |
10,200
-650
| -6% | -$72.5K |
|
49
State Street
STT
$32.1B
| $1.03M | 0.41% |
13,933
-1,100
| -7% | -$81K |
|
|
50
Xylem
XYL
$34B
| $860K | 0.35% |
24,253
+10,653
| +78% | +$378K |
|